Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.
Sign Up to like & getrecommendations! Published in 2018 at "Oncology letters"
DOI: 10.3892/ol.2017.7344
Abstract: Checkpoint kinase 1 (CHK1) and p53 are involved in cell-cycle checkpoint, and cellular response to DNA damage. CHK1 and p53 are overexpressed in bladder urothelial carcinoma (BUC); however, a clear elucidation on their interaction and… read more here.
Keywords: chk1 p53; buc; bladder urothelial; therapeutic targets ... See more keywords